Abstract. Rapid eye movement (REM) sleep is closely associated with nervous functions. The present study aimed to evaluate the effects of gabazine and tiagabine on the cognitive functions (CF) of REM sleep-deprived and sleep recovered rats. Rats were divided into REM sleep deprivation, blank control (CC) and environmental groups. The REM sleep deprivation group was further divided into non-operation (nonOP), sham-operated (Sham), gabazine (SR) and tiagabine groups. Each group was evaluated over five time points: Sleep deprived for 1 day (SD 1 day), SD 3 day, SD 5 day, sleep recovery 6 h (RS 6 h) and RS 12 h. A rat model of REM sleep deprivation was established by a modified multi-platform water method, with CF assessed by Morris water maze. Hypothalamic γ-aminobutyric acid (GABA) and glutamic acid contents were measured via high performance liquid chromatography. The number and morphology of hypocretin (Hcrt) neurons and Fos in the hypothalamus, and GABA A Rα1-induced integral optical density were detected by immunofluorescence. Compared to the CC group, the nonOP and Sham group rats CF were significantly diminished, Fos-positive and Fos-Hcrt double positive cells were significantly increased, and GABA content and GABA A Rα1 expression levels were significantly elevated (P<0.05). The tiagabine and CC groups exhibited similar results at three time points. The CF of rats in the SR group were diminished and the number of Fos-positive and Fos-Hcrt double positive cells were significantly increased (P<0.05) at RS 6 h and RS l2 h. GABA content and GABA A Rα1 expression levels were significantly increased in the SR group at all time points (P<0.05), whereas only GABA A Rα1 expression levels were significantly increased in the tiagabine group at SD 5 day (P<0.05). The results of the present study indicated that REM sleep deprivation diminished CF, increased the number of Hcrt neurons, GABA content and GABA A Rα1 expression. Furthermore, all alterations were positively correlated with deprivation time and corrected by sleep recovery, as demonstrated by single-factor multi-level variance analysis at the various time points in each group. Therefore, the Hcrt nervous system may be an eligible therapeutic target for the treatment of insomnia.
Introduction
Rapid eye movement (REM) sleep is important for the development and maturation of animal nervous systems and is associated with thermoregulation and autonomic nervous functions (1) . Cerebral oxygen consumption is significantly higher during the REM sleep period, as compared with the strong physical and mental activity states; and cerebral protein synthesis also significantly increases during REM sleep (2) . Therefore, REM sleep has an important role in advanced cerebral functions, including learning, memory and emotion, and is the predominant form of recovery for the human body (3, 4) . However, an increasing number of individuals are suffering from sleep deprivation of varying degrees (5) . Previous studies have demonstrated that REM sleep deprivation severely affects cognitive abilities, including learning, memory, logical reasoning, mathematical operations and decision-making, which are damaged to varying extents (6, 7) . The pathological mechanisms underlying this damage have yet to be fully elucidated.
The sleep-waking cycle is controlled by the two major systems of waking neurons and sleep-promoting neurons. Sleep-promoting neurons are predominantly composed of γ-aminobutyric acid (GABA) neurons, whereas waking neurons are more diverse (8) . Waking neurons comprise various neuronal systems, using numerous neurotransmitters including glutamic acid (Glu), noradrenaline, dopamine, 5-hydroxytryptamine, histamine and acetyl choline (9) . The hypocretin (Hcrt) system is correlated with the characterized waking neuron and sleep-promoting neuron systems (10) (11) (12) . The hypothalamus also has an important role in the regulation of the sleep-waking cycle. Perifornical nucleus (PeF) Hcrt neurons Effect of two GABA-ergic drugs on the cognitive functions of rapid eye movement in sleep-deprived and recovered rats receive intensive GABA fiber projection from the preoptic region, indicating that the Hcrt nervous system is associated with the GABA nervous system in the hypothalamus (13) (14) (15) .
In the present study, normal adult male rats were used to establish models of REM sleep deprivation in order to observe the effect of REM sleep deprivation and revival sleep (RS) of varying degrees on the cognitive functions (CF) of the rats. The following parameters were assessed: Number and morphology of Hcrt neurons; Fos expression levels in the lateral hypothalamic area (LH) of the hypothalamus; GABA content; and the expression of GABA A receptor α 1 subunit in the hypothalamus. The present study aimed to investigate the effect of REM sleep deprivation on the activity of the hypothalamic Hcrt nervous system and GABA nervous system, as well as the interaction between the two neuron systems and their association with the diminished CF arising from REM sleep deprivation via cerebral stereotaxic surgery and intervention with a PeF micro-dialysis GABA A receptor antagonist, gabazine, and GABA re-uptake inhibitor, tiagabine.
Materials and methods

Experimental animals and groups.
A total of 180 male Sprague-Dawley rats, aged 14-16 years and weighing 250-280 g, were purchased from Nanjing Better Biotechnology Co., Ltd. (Nanjing, China). All rats were housed in a controlled temperature (22˚C) and under a 12-h light/dark cycle with ad libitum access to food and water. The rats were randomly divided into control (n=60) and REM sleep deprivation (n=120) groups. The control group was subdivided into blank control (CC) and environmental control (TC) groups (n=30 rats/group), and the REM sleep deprivation group was subdivided into the non-operative control (nonOP), sham operation control (Sham), gabazine (SR) and tiagabine groups (n=30 rats/group). Each group was evaluated at five points in time: Sleep deprived for 1 day (SD 1 day), SD 3 day, SD 5 day, sleep recovery 6 h (RS 6 h) and RS 12 h. At total of 6 rats were evaluated at each time point. Following weighing, the rats were maintained in the same cage. The present study was approved by the Ethics Committee of Inner Mongolia Medical University (Hohhot, China). (16) .
Reagents and instruments.
Establishment of REM sleep deprivation rat models. Based on the rat localization map outlined by Paxinos and Watson (17) , PeF was selected in the rats of the Sham, gabazine and tiagabine groups. A hole (diameter, 1.0 mm) was drilled and a stainless steel sleeve was vertically implanted once the cerebrospinal fluid had outflowed. A modified multiple platform REM sleep deprivation method was used to establish a REM sleep deprivation model, as previously described (18) . Rats were awoken by nutation or water immersion in order to prevent the rats from entering the REM sleep period, thus leading to REM sleep deprivation. The muscle tone of the rats decreased when they entered the REM sleep period. Rats stayed on the platform for 1 week (1 h daily) prior to the experiment. Subsequently, the Morris water maze test was used to determine alterations in the CF of the rats, as assessed by the escape latencies and space exploratory behavior, following REM sleep deprivation for varying durations and sleep recovery.
Micro-dialysis administration. Micro-dialysis administration was performed on the rats in the Sham, SR, and tiagabine groups during REM sleep deprivation at 8:00-10:00 a.m. each morning (19) . Injection was performed slowly at a speed of 1 µl/30 sec. The rats in the Sham group were injected with 1 µl aCSF, whereas 0.2 µM/µl gabazine and 0.5 µM/µl tiagabine were dissolved in 1 µl aCSF and injected into the rats in the gabazine and tiagabine groups, respectively. The hypothalamic PeF region was observed in CSF extraction to assess the effects of the gabazine GABA A receptor antagonist and tiagabine GABA re-uptake inhibitor.
Immunofluorescence staining to assess c-Fos expression in the LH Hcrt neurons of rats. Complete hypothalamus brain tissue was harvested from between the optic chiasma and mammillary body posterior, which was cut vertically and coronally (20, 21) . Brain tissue was cut into 20 µm-thick coronal serial sections using a VT1200 S tissue slicer. There were three groups of tissue sections and the sections from each group were stored in separate specimen boxes. The tissue sections were incubated at room temperature for 24 h with rabbit anti-Hcrt A (1:200) and mouse anti-c-Fos (1:4,000) monoclonal antibodies. Following washing three times for 5 min each with PBS, the tissue sections were incubated at room temperature for 4 h with FITC-conjugated goat anti-rabbit IgG (1:200), Cy3-conjugated goat anti-rabbit IgG (1:200) and HRP-conjugated goat anti-mouse IgG (1:100). For visualization of the HRP-conjugated secondary antibody, the tissue sections were incubated with 3,3-diaminobenzidine (cat.
no. P0203; DAB Horseradish Peroxidase Color Development kit; Beyotime Institute of Biotechnology, Haimen, China). In the blank control group, normal rabbit and goat serum were used as substitutes. Control tissue sections were taken and the steps were completed as before. Staining was evaluated by observation with a Nikon E600 fluorescence microscope. Images were captured and analyzed using the QWin Plus image analysis system.
Determination of GABA and Glu content in the hypothalamus
of the rats. The hypothalamus was harvested and cut into sections (22, 23) . A total of 10 mg hypothalamus tissue was weighed and centrifuged at 5,000 x g at 0˚C for 15 min. The supernatant was dissolved in the aCSF at a concentration of 1.0 mmol/l and refrigerated. The solution was diluted to 10X and 100X with aCSF prior to use. Varian Prostar 230 HPLC, Star 9075 fluorescence detector and Star software were used for gradient control and chromatographic data treatment and determination of the content of GABA and Glu in the hypothalamus. A calibration curve was plotted with standard concentration vs. peak area. Specimen concentrations were calculated using the external standard method.
Immunofluorescence detection of GABA A Rα1 σ-subunit expression in the hypothalamus of rats. The third group of tissue sections were incubated at room temperature for 24 h with rabbit anti-GABA A Rαl antibody (1:200), as previously described (24) . The tissue sections were subsequently incubated at room temperature for 4 h with Cy3-conjugated goat anti-rabbit IgG antibody (1:200). Normal rabbit and goat serum served as the negative control and the subsequent steps were completed as before. The tissue sections were observed under a low-power microscope (Olympus CX23; Olympus Corporation, Tokyo, Japan) to determine the positive expression region. Five fields were selected under a high-power microscope (XTJ-4400; Wuzhou New Found Instrument, Co., Ltd., Wuzhou, China) and an Image Pro Plus 7.0 software was used to analyze the images. The integrated optical density (IOD) was measured on the yellow portion of the image.
Statistical treatment. SPSS 17.5 statistical software (SPSS, Inc., Chicago, IL, USA) was used to perform the statistical analyses. Data were expressed as the mean ± standard error of the mean. Self-control data prior to and following REM sleep deprivation at each time point in each group were subjected to a t-test of randomized matched pair design data mean. The Levene's test was used to assess homogeneity of variance. Single factor multilevel variance analysis was used to analyze comparisons at various time points in each group. Inter-group comparisons at various time points were assessed via multi-factor variance analysis. P<0.05 was considered to indicate a statistically significant difference.
Results
Cognitive behavior. Based on the comparison between the nonOP group and Sham group, and the CC group and TC group, the CF at three points in time, SD 3 day, SD 5 day ------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------ and RS 6 h diminished significantly (P<0.05); however no significant difference in CF was detected at SD 1 day and RS 12 h. The CF of the rats in the SR group were significantly diminished at SD 1 day, SD 3 day, and SD 5 day (P<0.05), whereas no significant difference in CF was detected at RS 6 h and RS 12 h, as compared with the CC and TC groups. Furthermore, no significant difference in CF was detected in the rats in the tiagabine group at SD 1 day, SD 3 day and SD 5 day, as compared with the CC and TC groups; although CF were significantly diminished at SD 1 day and RS 12 h (P<0.05; Tables I and II; Fig. 1 ). GABA and Glu content in the hypothalamus of rats. No significant differences in GABA and Glu content was detected in the hypothalamus of rats in the TC and CC groups at various time points. Furthermore, no significant differences in Glu content were detected between the various time points in all groups. GABA content was significantly increased in the nonOP, Sham and gabazine groups at SD 1 day, SD 3 day, SD 5 day and RS 6 h, as compared with the CC and TC groups (P<0.05). GABA content in the gabazine group at RS 12 h was significantly increased, as compared with the CC and TC groups (P<0.05). No significant differences in GABA were detected in the remaining five groups, as compared with the CC and TC groups. Minor alterations in GABA content were detected in the tiagabine group prior to REM sleep deprivation and following sleep recovery. No significant differences in GABA content was detected at the five time points in the 
Immunofluorescence staining for c-Fos expression in LH
Immunofluorescence detection of GABA A Rα1 σ-subunit expression in the hypothalamus of rats.
Fluorescence microscopy demonstrated that the Cy3-stained GABA A Rα1 σ-subunits were densely distributed in the whole hypothalamus region and cavities of various sizes were formed at few sites. The immunofluorescence of the tissue sections at SD 1 day, SD 3 day, SD 5 day and RS 6 h in the nonOP, Sham and gabazine groups was significantly increased, as compared with the remaining time points in the remaining groups. Immunofluorescence peaked at SD 5 day in the gabazine group. For the assessment of the GABA A Rα1 σ-subunit immunofluorescence IOD, only the result at SD 5 day in the tiagabine group was higher compared with the CC and TC groups (P>0.05). No significant differences in the IOD values of the GABA A Rα1 positive regions within the hypothalamus were detected between the TC and CC groups at various time points. IOD values of the GABA A Rα1-positive regions were significantly increased in nonOP, Sham and gabazine groups at SD 1 day, SD 3 day, SD 5 day and RS 6 h, as compared with the CC and TC groups (P<0.05). At SD 5 day, the IOD value of the GABA A Rα1 positive regions in the tiagabine group was significantly higher, as compared with the CC and TC groups (P<0.05). The IOD value of the GABA A Rα1 positive regions at RS 12 h in the gabazine group was still significantly increased, as compared with the CC and TC groups at only SD 5 day (P<0.05). No statistical differences in IOD values were detected between the remaining five groups and the CC and TC groups at the RS 12 h (Table V; Figs. 4B and 5).
Discussion
To date, various behavioristic methods have been used to investigate learning and memory. The Morris water maze is a universally-accepted objective method for evaluating behavior (25) . Rodents are more similar to humans than other animals in sleep physiology (26) ; therefore rodents are the most suitable for medical research and male rats were selected as the subjects in the present study. Previous studies have determined that rats may succumb to REM sleep deprivation after 6-7 days (27, 28) . Therefore, in order to avoid data loss due to mortality, the maximum duration of REM sleep deprivation was 5 days in the present study. As it is difficult to distinguish the alterations in CF and other indices, including c-Fos (29, 30) , five points in time (SD 1 day, SD 3 day, SD 5 day, RS 6 h, and RS 12 h) were selected for observation.
Comparing the alterations in CF among and within groups demonstrated that the overall variation CF trend in the tiagabine group was consistent with the nonOP and Sham groups, although the degrees of alteration were different. At SD 1 day in the tiagabine group, rats exhibited significantly diminished CF, as compared with the CC and TC groups; whereas no differences were detected between the nonOP and Sham groups and the latter two groups. Rats in the tiagabine group exhibited diminished CF at SD 1 day, SD 3 day and SD 5 day, as compared with the nonOP and Sham groups. Furthermore, the CF of rats at RS 6 h in the tiagabine group exhibited improved recovery, as compared with the nonOP and Sham groups; however, there was no significant difference at RS 12 h among these three groups. These results indicated that the GABA re-uptake inhibitor exacerbated the decline of CF in the rats during REM sleep deprivation, whereas it accelerates the improvement of CF following sleep recovery. This is consistent with previous studies which have demonstrated that GABA pharmacological agents can be used to effectively intervene with the alterations in CF during REM sleep deprivation and recovery in rats (31, 32) .
The number of F + &H + cells in the lateral region of the hypothalamus of the rats in the nonOP group following REM sleep deprivation at SD 1 day, SD 3 day and SD 5 day was significantly increased, as compared with the CC and TC Table IV . GABA and Glu content (µmol/l) in the hypothalamus of REM sleep-deprived rats in the various groups (n=6 rats/group). ---------------------------------------------------------------------------------------- Therefore, this suggests that the GABA nerve system may also participate in the regulation of increased Hcrt nerve system activity arising from REM sleep deprivation.
In the present study, GABA content and GABA A Rα1 expression in the hypothalamus significantly increased among normal rats following REM sleep deprivation in the nonOP group. The degree of this increase was positively correlated with the duration of REM sleep deprivation and, although it returned back to normal following sleep recovery, remained higher than the CC and TC groups. No differences between the CC and TC groups were detected at RS 12 h. This increase in GABA content and GABA A Rα1 expression indicated that the GABA nerve system strengthens. Therefore suggesting that REM sleep deprivation is capable of strengthening the role of the GABA nerve system in the hypothalamus.
In the present study, the degree of increase was positively correlated with the duration of REM sleep deprivation. However, it was demonstrated that this alteration returns to normal at RS 12 h. During REM sleep deprivation and recovery, the GABA nerve system has its own regulation mechanism, which is a protective physiological process (34) . The role of the GABA nerve system is positively correlated with the damage to the CF; therefore a stronger role of the GABA nerve system will induce more severe damage to CF (35) . Furthermore, the activity of the Hcrt nerve system is positively correlated with the GABA nerve system, as one regulates the other (36) .
In conclusion, in terms of the decline of CF in rats induced by REM sleep deprivation, the GABA nerve system is not an ideal therapeutic target for the treatment of insomnia, whereas the Hcrt nerve system may hold greater potential as a therapeutic target.
